INSMED Inc — Director's Dealing 2023

Jun 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-06-13

Reporting Person: Flammer Martina M.D. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-13	Common Stock	S	8868	$19.27	Disposed	106038	Direct

Footnotes

F1: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2023.

F2: This is the weighted average sales price representing 8,868 shares sold at prices ranging from $19.23 to $19.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.